Management of Warfarin for Dental Procedures
For most routine dental procedures, warfarin therapy should be continued without interruption, with appropriate local hemostatic measures used to control bleeding. 1, 2
Risk Stratification Approach
Low-Risk Dental Procedures
- Continue warfarin therapy without dose modification for routine dental procedures such as simple tooth extractions 1
- Check INR during the week before the procedure to ensure it is within therapeutic range (ideally ≤3.5) 1, 3
- If INR is within therapeutic range, continue with usual daily dose 4, 5
- If INR is above therapeutic range but <5, reduce daily warfarin dose until INR returns to therapeutic range 4, 5
- If INR >5, defer the procedure and contact the anticoagulation clinic for advice 4
High-Risk Dental Procedures
- For extensive oral surgery with higher bleeding risk in patients with low thrombotic risk, consider discontinuing warfarin 5 days before the procedure 6, 5
- Check INR prior to the procedure to ensure it is <1.5 6, 5
- Restart warfarin with usual daily dose on the evening of the procedure 6, 5
- Check INR one week later to ensure adequate anticoagulation 4, 5
High-Risk Dental Procedures in High Thrombotic Risk Patients
- For patients at high risk of thromboembolism (e.g., recent thromboembolic event <3 months), warfarin should be temporarily discontinued and substituted with LMWH 6, 5
- Stop warfarin 5 days before the procedure 4, 5
- Two days after stopping warfarin, commence daily therapeutic dose of LMWH 4, 5
- Administer the last dose of LMWH at least 24 hours prior to the procedure 4, 5
- Check INR prior to the procedure to ensure it is <1.5 4, 5
- Resume warfarin on the day of the procedure with usual daily dose 4, 5
- Restart LMWH the day after the procedure and continue until a satisfactory INR is achieved 4, 5
Evidence Supporting Continued Warfarin
- Research shows that simple tooth extraction in patients on warfarin can be performed safely without high risk of bleeding when INR is ≤3.5 3
- A randomized controlled trial found no significant difference in clinically important bleeding between patients who continued versus stopped warfarin for dental extractions 7
- Meta-analysis confirms that continuing regular warfarin dose does not confer increased risk of bleeding compared to discontinuing or modifying the dose for minor dental procedures 8
- The risk of thromboembolic events from interrupting anticoagulation typically outweighs the risk of bleeding during dental procedures 1
Local Hemostatic Measures
- For all patients on warfarin, advise that there is an increased risk of post-procedure bleeding compared to non-anticoagulated patients 4
- Use local hemostatic measures including:
Common Pitfalls and Caveats
- Discontinuing warfarin for simple dental procedures can lead to unnecessary risk of thromboembolic events 1, 2
- Even with continued warfarin therapy, moderate bleeding may occur in approximately 11-26% of cases, but this is typically manageable with local measures 3, 7
- Patients with INR >3.5 may have higher risk of bleeding complications and should be evaluated on a case-by-case basis 3, 2
- Close follow-up and monitoring of patients taking warfarin is mandatory after dental extraction 3
- When warfarin must be discontinued, minimize the time off the medication to reduce thrombotic risk 6
By following this algorithmic approach based on procedure risk and patient thrombotic risk, dental procedures can be performed safely while minimizing both bleeding and thrombotic complications.